Investor relations

At Mölnlycke, we're driven by a passion for improving healthcare outcomes through innovation and excellence. We are transparent about our strategic objectives, financial performance, and commitment to sustainable growth. We deeply appreciate your interest and trust in Mölnlycke. Your support fuels our mission to make a meaningful impact in healthcare and deliver long-term value to our shareholders.

Mölnlycke key performance stats 2023

  • 0 %
    organic sales growth
  • 0
    EBITDA, million EUR
  • 0
    annual sales, million EUR

"With strong growth and substantial improvements in profitability, I am confident that we are on the right track"

Zlatko Rihter Chief Executive Officer

Mölnlycke is owned by Investor AB. Investor AB is listed on NASDAQ QMX Stockholm.

Read more

In 2023, Mölnlycke showcased a strong performance, with organic sales increasing by 8% and achieving annual sales totaling EUR 1,924 million. The increase in sales was primarily driven by Wound Care and Operating Room Solutions.

Furthermore, Mölnlycke enhanced its profitability, achieving an EBITDA of EUR 545 million with a corresponding margin of 28%. This positive outcome was 
mainly influenced by substantial organic volume and mix growth. Cost reductions 
in sourcing and material handling further contributed to the favourable results.

Financial information

  • We are transparent about our impact on environment, people and society. Each year, we report on results and performance in the integrated Annual Report.

    Mölnlycke integrated Annual Report 2023 covers the year ending on 31 December 2023. The report has been prepared in accordance with Global Reporting Initiative (GRI) standards, in addition to the Taskforce on Climate related Financial Disclosures (TCFD) framework.

    Read our Annual report

  • Capital Markets Day 2023 Presentation

  • Mölnlycke issues notes on the European bond market under its Euro Medium Term Note (EMTN) programme. Mölnlycke has an outstanding debt of EUR 2.073 million which is long-dated and evenly distributed.

    In addition to its own liquidity, Mölnlycke has a syndicated multi-currency revolving credit facility of EUR 350 million (unutilised) with a due date in 2029. The facility is backed by a group of seven leading global and regional banks, well diversified to match Mölnlycke’s geographical footprint. The banks are BNP, Danske Bank, HSBC, ING, JP Morgan, Nordea and SEB.

    Debt maturity profile

  • Mölnlycke and Investor AB are committed to the company’s Investment Grade rating of BBB- (stable) by S&P.

    S&P outlook:

    Our stable outlook on Mölnlycke reflects our view that the company's leading market position and strong brand portfolio should enable it to sustain positive underlying revenue growth and earnings generation.